• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
UCM
Click for more information
0.00% 3.2¢

USCOM LIMITED - Announcements

Market Cap $3.506M  ! watchlist Created with Sketch. Add to my watchlist

Uscom Limited is a medical technology company. It specializes in the development and... Uscom Limited is a medical technology company. It specializes in the development and marketing of non-invasive cardiovascular and pulmonary medical devices. It has three suites of devices in the field of cardiac, vascular, and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities, and is used to guide treatment. The USCOM 1A device has applications in emergency, intensive care medicine and anesthesia. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms in the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. Its VENTITEST digital ultrasonic ventilator testing solution is a new system for testing ventilators.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
UCM Uscom Granted Type II Medical Device Sales Cert in ChinaPRICE SENSITIVE25/03/19
UCM Change in substantial holding - Meng21/03/19
UCM Half Year AccountsPRICE SENSITIVE28/02/19
UCM Clarification related to Unissued Indeterminate Rights25/02/19
UCM Uscom Signs SpiroSonic Deal with US eHealth Leader - KoneksaPRICE SENSITIVE07/02/19
UCM Appendix 4C - quarterlyPRICE SENSITIVE29/01/19
UCM Cleansing statement14/01/19
UCM Appendix 3B14/01/19
UCM Results of Meeting28/11/18
UCM Uscom Ltd 2018 AGM PresentationPRICE SENSITIVE28/11/18
UCM Uscom China IP GrantedPRICE SENSITIVE19/11/18
UCM Uscom China RegisteredPRICE SENSITIVE12/11/18
UCM Appendix 4C - quarterlyPRICE SENSITIVE29/10/18
UCM Notice of Annual General Meeting/Proxy Form25/10/18
UCM Appendix 3B04/10/18
UCM Corporate Governance Statement31/08/18
UCM Appendix 4G31/08/18
UCM Initial Director's Interest Notice - Crowley23/08/18
UCM Director Appointment/Resignation23/08/18
UCM Annual Report to shareholders22/08/18
UCM Preliminary Final ReportPRICE SENSITIVE22/08/18
UCM Uscom releases new hypertension productPRICE SENSITIVE02/08/18
UCM Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
UCM Investor Update24/07/18 download Created with Sketch. 3.39MB
UCM New Uscom Measure of Heart FunctionPRICE SENSITIVE21/06/18 download Created with Sketch. 475.8KB
UCM Change of Director's Interest Notice - Phillips15/06/18 download Created with Sketch. 172.64KB
UCM App 3B -Guo08/06/18 download Created with Sketch. 459.47KB
UCM China and Investor Update May1828/05/18 download Created with Sketch. 488.69KB
UCM New US IP for Uscom SpiroSonic DevicesPRICE SENSITIVE24/05/18 download Created with Sketch. 480.54KB
UCM Final Director's Interest Notice - Mr He23/05/18 download Created with Sketch. 172.94KB
UCM Director Resignation - Mr He23/05/18 download Created with Sketch. 107.61KB
UCM Appendix 4C - quarterlyPRICE SENSITIVE23/04/18
UCM Uscom Asia Investment Non Deal April 201810/04/18
UCM Uscom Investor Update March 201814/03/18
UCM BP Plus for US eHealth studyPRICE SENSITIVE06/03/18
UCM Uscom Investor Update March 201828/02/18
UCM Half Yearly Report and AccountsPRICE SENSITIVE14/02/18
UCM Uscom BP Plus Approved by International Hypertension Society12/02/18
UCM Change in substantial holding05/02/18
UCM Appendix 4C - quarterlyPRICE SENSITIVE31/01/18
UCM Change in substantial holding18/01/18
UCM Change in substantial holding08/01/18
UCM Change of Director's Interest Notice08/01/18
UCM Appendix 3B08/01/18
UCM Cleansing Notice08/01/18
UCM Becoming a substantial holder - STOL22/12/17
UCM Cleansing statement21/12/17
UCM Appendix 3B21/12/17
UCM CE Mark for Uscom BP Plus Sale in Europe20/12/17
UCM Share placementPRICE SENSITIVE19/12/17
UCM International Value Investor Takes Strategic Stake in UscomPRICE SENSITIVE18/12/17
UCM Uscom Receives $492K R&D Cash RefundPRICE SENSITIVE15/12/17
UCM Trading HaltPRICE SENSITIVE15/12/17
UCM Investor Presentation December 201714/12/17
UCM Change in substantial holding08/12/17
UCM Change of Director's Interest Notice08/12/17
UCM Change of Director's Interest Notice08/12/17
UCM Appendix 3B08/12/17
UCM Cleansing Notice08/12/17
UCM New Hypertension Study Recommends Uscom BP Plus MeasuresPRICE SENSITIVE21/11/17
UCM Details of Company Address16/11/17
UCM Uscom receives GSA listing to sell to US GovernmentPRICE SENSITIVE13/11/17
UCM Results of 2017 AGM08/11/17
UCM Uscom Ltd 2017 AGM Presentation08/11/17
UCM Uscom BP plus Central Blood Pressure Monitor ReleasedPRICE SENSITIVE30/10/17
UCM Appendix 4C - quarterlyPRICE SENSITIVE27/10/17
UCM BP Plus and Mount Everest Hypertension StudyPRICE SENSITIVE16/10/17
UCM USCOM cost effective replacement for ICU UltrasoundPRICE SENSITIVE09/10/17
UCM AGM - Withdrawal of Resolution 606/10/17
UCM Notice of Annual General Meeting/Proxy Form28/09/17
UCM Appendix 3B06/09/17
UCM Cleansing Notice06/09/17
UCM Appendix 4G31/08/17
UCM Preliminary Final ReportPRICE SENSITIVE22/08/17
UCM Annual Report to shareholdersPRICE SENSITIVE21/08/17
UCM New USCOM 1A digital connectivity feature releasedPRICE SENSITIVE09/08/17
UCM Expiry of options07/08/17
UCM Appendix 4C - quarterlyPRICE SENSITIVE25/07/17
UCM Uscom BPplus Distributor for SE AsiaPRICE SENSITIVE17/07/17
UCM TGA for Uscom SpiroSonic Digital SpirometersPRICE SENSITIVE13/07/17
UCM Euro Funding for Uscom Pulmonary ResearchPRICE SENSITIVE11/07/17
UCM Appendix 3B05/07/17
UCM Cleansing Notice - Issue of Shares05/07/17
UCM Uscom SpiroSonic Devices for Spanish Health ProjectPRICE SENSITIVE01/06/17
UCM Uscom SpiroSonic Devices for French Lung Transplant StudyPRICE SENSITIVE24/05/17
UCM Uscom boosts global sales and marketingPRICE SENSITIVE01/05/17
UCM Uscom Achieves First Cash Flow Positive Quarter Appendix 4CPRICE SENSITIVE19/04/17
UCM Uscom Achieves First Cash Flow Positive QuarterPRICE SENSITIVE19/04/17
UCM 2017 Q3 Update - Continued Growth07/04/17
UCM New Uscom Euro Grant for Pulmonary ResearchPRICE SENSITIVE03/04/17
UCM New USCOM Evidence for PreeclampsiaPRICE SENSITIVE30/03/17
UCM China BP Plus and SpiroSonic Regulatory SubmissionsPRICE SENSITIVE22/03/17
UCM Uscom Receives $0.5M R&D Cash RefundPRICE SENSITIVE20/03/17
UCM New BP Plus PatentPRICE SENSITIVE06/03/17
UCM Half Yearly Report and AccountsPRICE SENSITIVE13/02/17
UCM Appendix 4C - quarterlyPRICE SENSITIVE31/01/17
UCM Uscom BPplus Detects New Evidence of Cardiovascular DiseasePRICE SENSITIVE19/01/17
UCM 2017 Update Continued Growth16/01/17
UCM Change in substantial holding04/01/17
UCM Change of Director's Interest Notice04/01/17
UCM Uscom Granted Type II Medical Device Sales Cert in China
25/03/19PRICE SENSITIVE
UCM Change in substantial holding - Meng
21/03/19
UCM Half Year Accounts
28/02/19PRICE SENSITIVE
UCM Clarification related to Unissued Indeterminate Rights
25/02/19
UCM Uscom Signs SpiroSonic Deal with US eHealth Leader - Koneksa
07/02/19PRICE SENSITIVE
UCM Appendix 4C - quarterly
29/01/19PRICE SENSITIVE
UCM Cleansing statement
14/01/19
UCM Appendix 3B
14/01/19
UCM Results of Meeting
28/11/18
UCM Uscom Ltd 2018 AGM Presentation
28/11/18PRICE SENSITIVE
UCM Uscom China IP Granted
19/11/18PRICE SENSITIVE
UCM Uscom China Registered
12/11/18PRICE SENSITIVE
UCM Appendix 4C - quarterly
29/10/18PRICE SENSITIVE
UCM Notice of Annual General Meeting/Proxy Form
25/10/18
UCM Appendix 3B
04/10/18
UCM Corporate Governance Statement
31/08/18
UCM Appendix 4G
31/08/18
UCM Initial Director's Interest Notice - Crowley
23/08/18
UCM Director Appointment/Resignation
23/08/18
UCM Annual Report to shareholders
22/08/18
UCM Preliminary Final Report
22/08/18PRICE SENSITIVE
UCM Uscom releases new hypertension product
02/08/18PRICE SENSITIVE
UCM Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
UCM Investor Update
24/07/18 download Created with Sketch. 3.39MB
UCM New Uscom Measure of Heart Function
21/06/18PRICE SENSITIVE download Created with Sketch. 475.8KB
UCM Change of Director's Interest Notice - Phillips
15/06/18 download Created with Sketch. 172.64KB
UCM App 3B -Guo
08/06/18 download Created with Sketch. 459.47KB
UCM China and Investor Update May18
28/05/18 download Created with Sketch. 488.69KB
UCM New US IP for Uscom SpiroSonic Devices
24/05/18PRICE SENSITIVE download Created with Sketch. 480.54KB
UCM Final Director's Interest Notice - Mr He
23/05/18 download Created with Sketch. 172.94KB
UCM Director Resignation - Mr He
23/05/18 download Created with Sketch. 107.61KB
UCM Appendix 4C - quarterly
23/04/18PRICE SENSITIVE
UCM Uscom Asia Investment Non Deal April 2018
10/04/18
UCM Uscom Investor Update March 2018
14/03/18
UCM BP Plus for US eHealth study
06/03/18PRICE SENSITIVE
UCM Uscom Investor Update March 2018
28/02/18
UCM Half Yearly Report and Accounts
14/02/18PRICE SENSITIVE
UCM Uscom BP Plus Approved by International Hypertension Society
12/02/18
UCM Change in substantial holding
05/02/18
UCM Appendix 4C - quarterly
31/01/18PRICE SENSITIVE
UCM Change in substantial holding
18/01/18
UCM Change in substantial holding
08/01/18
UCM Change of Director's Interest Notice
08/01/18
UCM Appendix 3B
08/01/18
UCM Cleansing Notice
08/01/18
UCM Becoming a substantial holder - STOL
22/12/17
UCM Cleansing statement
21/12/17
UCM Appendix 3B
21/12/17
UCM CE Mark for Uscom BP Plus Sale in Europe
20/12/17
UCM Share placement
19/12/17PRICE SENSITIVE
UCM International Value Investor Takes Strategic Stake in Uscom
18/12/17PRICE SENSITIVE
UCM Uscom Receives $492K R&D Cash Refund
15/12/17PRICE SENSITIVE
UCM Trading Halt
15/12/17PRICE SENSITIVE
UCM Investor Presentation December 2017
14/12/17
UCM Change in substantial holding
08/12/17
UCM Change of Director's Interest Notice
08/12/17
UCM Change of Director's Interest Notice
08/12/17
UCM Appendix 3B
08/12/17
UCM Cleansing Notice
08/12/17
UCM New Hypertension Study Recommends Uscom BP Plus Measures
21/11/17PRICE SENSITIVE
UCM Details of Company Address
16/11/17
UCM Uscom receives GSA listing to sell to US Government
13/11/17PRICE SENSITIVE
UCM Results of 2017 AGM
08/11/17
UCM Uscom Ltd 2017 AGM Presentation
08/11/17
UCM Uscom BP plus Central Blood Pressure Monitor Released
30/10/17PRICE SENSITIVE
UCM Appendix 4C - quarterly
27/10/17PRICE SENSITIVE
UCM BP Plus and Mount Everest Hypertension Study
16/10/17PRICE SENSITIVE
UCM USCOM cost effective replacement for ICU Ultrasound
09/10/17PRICE SENSITIVE
UCM AGM - Withdrawal of Resolution 6
06/10/17
UCM Notice of Annual General Meeting/Proxy Form
28/09/17
UCM Appendix 3B
06/09/17
UCM Cleansing Notice
06/09/17
UCM Appendix 4G
31/08/17
UCM Preliminary Final Report
22/08/17PRICE SENSITIVE
UCM Annual Report to shareholders
21/08/17PRICE SENSITIVE
UCM New USCOM 1A digital connectivity feature released
09/08/17PRICE SENSITIVE
UCM Expiry of options
07/08/17
UCM Appendix 4C - quarterly
25/07/17PRICE SENSITIVE
UCM Uscom BPplus Distributor for SE Asia
17/07/17PRICE SENSITIVE
UCM TGA for Uscom SpiroSonic Digital Spirometers
13/07/17PRICE SENSITIVE
UCM Euro Funding for Uscom Pulmonary Research
11/07/17PRICE SENSITIVE
UCM Appendix 3B
05/07/17
UCM Cleansing Notice - Issue of Shares
05/07/17
UCM Uscom SpiroSonic Devices for Spanish Health Project
01/06/17PRICE SENSITIVE
UCM Uscom SpiroSonic Devices for French Lung Transplant Study
24/05/17PRICE SENSITIVE
UCM Uscom boosts global sales and marketing
01/05/17PRICE SENSITIVE
UCM Uscom Achieves First Cash Flow Positive Quarter Appendix 4C
19/04/17PRICE SENSITIVE
UCM Uscom Achieves First Cash Flow Positive Quarter
19/04/17PRICE SENSITIVE
UCM 2017 Q3 Update - Continued Growth
07/04/17
UCM New Uscom Euro Grant for Pulmonary Research
03/04/17PRICE SENSITIVE
UCM New USCOM Evidence for Preeclampsia
30/03/17PRICE SENSITIVE
UCM China BP Plus and SpiroSonic Regulatory Submissions
22/03/17PRICE SENSITIVE
UCM Uscom Receives $0.5M R&D Cash Refund
20/03/17PRICE SENSITIVE
UCM New BP Plus Patent
06/03/17PRICE SENSITIVE
UCM Half Yearly Report and Accounts
13/02/17PRICE SENSITIVE
UCM Appendix 4C - quarterly
31/01/17PRICE SENSITIVE
UCM Uscom BPplus Detects New Evidence of Cardiovascular Disease
19/01/17PRICE SENSITIVE
UCM 2017 Update Continued Growth
16/01/17
UCM Change in substantial holding
04/01/17
UCM Change of Director's Interest Notice
04/01/17
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
3.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.506M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 1000 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 66058 2
View Market Depth
Last trade - 16.12pm 22/11/2024 (20 minute delay) ?
UCM (ASX) Chart

Top Stories

ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024

The ASX 200 is tipped to rise as much as 1% at open today after Wall Street enjoyed another major @Trump trade” surge buoyed by year-end optimism.The Dow Jones leaped 1.06% amid the U.S. jump, with the S@P 500 following close behind with a 0.53% rise @ a trend the Aussie bou...
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
IP anomaly thrills Cannidah with project extension hopes in QLD Cannidah Resources has carried out geophysical work at its flagship project in Queensland which highlighted an IP anomaly.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.